Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Not recruiting

1 1 1 1
Investigated drugs:
+5
Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Not recruiting

1 1 1
Investigated drugs:
Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

1 1
Investigated drugs:
- Belantamab Mafodotin
+1
Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Not recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma
- Plasma cell myeloma refractory
Investigated drugs:
+4
Study on the Effectiveness of Talquetamab and Teclistamab in First-Line Treatment for Transplant-Eligible Multiple Myeloma Patients

Not recruiting

1 1 1
Investigated drugs:
Study on Teclistamab and Drug Combination for Newly Diagnosed Multiple Myeloma Patients

Not recruiting

1 1 1
Investigated drugs:
Study on Venetoclax and Dexamethasone for Patients with Relapsed and Refractory Multiple Myeloma with Translocation (11;14)

Not recruiting

1 1 1
Investigated drugs:
Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Not recruiting

1 1 1 1
Investigated drugs:
+8
Study Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant

Not recruiting

1 1 1 1
Investigated drugs:
+10
Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

1 1 1 1
Investigated drugs:
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes